17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
After notice of proposed rulemaking and request for comments, the NLRB released its final rule for g...
Read More >
In December 2019, Congress passed the Setting Every Community Up for Retirement Enhancement Act of 2...
Read More >
J&F Investmentos SA (“J&F), a Brazilian private investment company, plead guilty to FCPA bribery vi...
Read More >
There is nothing wrong with being thrifty. You should never pay the full price for something that yo...
Read More >
On May 28, 2019, the Maryland Governor permitted (without signature) the Noncompete and Conflict of ...
Read More >
When outside forces pose a threat to people’s livelihood, people will go to great lengths to fight ...
Read More >